Vlad Coric: key facts
- Kind of voice
- Sector leader
- Role
- CEO of Biohaven
- Quoted on
- Rare diseases
- Tracked press citations
- 2
- Most recently quoted
- 30 Sept 2026
“Decried a 'systemic problem' at the FDA and warned of a 'dire time' for rare disease patients.”
What Vlad Coric has said
“condemned a "systemic problem" at the FDA and warned of a "difficult period" for patients with rare diseases”
director at Biohaven · Rare diseases · 30 Sept 2026 · Orphan drugs gain momentum: $409 billion by 2032 ↗
Where Vlad Coric has been quoted
- Rare disease drug sales to surge past $400B by 2032 despite FDA volatility: Evaluate reportfiercepharma.com · 30 Sept 2026
- Orphan drugs gain momentum: $409 billion by 2032gxpnews.net · 30 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.